Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Helmut
★★★

Vienna, Austria,
2013-12-06 02:54
(4176 d 16:09 ago)

Posting: # 12010
Views: 5,309

EMA: Draft product-specific guidance ♬ [BE/BA News]

Dear all,

after the first 16 guidances EMA keeps going. The complete list with the respective end of consultation here.

Sunitinib published 2013-12-04
50 mg single dose cross-over in healthy subjects (fasting state), parent in plasma (achiral),
AR 80.00–125.00% for AUC₇₂ and C_max (HVD status not reviewed).

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
151 visitors (0 registered, 151 guests [including 22 identified bots]).
Forum time: 20:04 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other. Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz